Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.53 USD | -2.97% | -0.31% | -1.06% |
09/05 | Nkarta, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
26/03 | Canaccord Genuity Adjusts Nkarta's Price Target to $16 From $15, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.06% | 47Cr | |
+8.63% | 12TCr | |
+13.17% | 11TCr | |
-12.76% | 2.23TCr | |
-3.99% | 2.16TCr | |
-7.19% | 1.82TCr | |
-39.93% | 1.76TCr | |
+6.67% | 1.43TCr | |
+33.90% | 1.24TCr | |
-28.60% | 828.11Cr |
- Stock Market
- Equities
- NKTX Stock
- News Nkarta, Inc.
- Nkarta Says Leukemia Drug Showed 'Encouraging' Results in Phase 1 Study